Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 609 | 483 | 631 | 587 | 609 |
| Accounts receivable | 404 | -11 | -165 | -91 | -50 |
| Other Working Capital | -922 | 801 | -807 | -686 | -538 |
| Other Operating Activity | -8,319 | -6,248 | -8,344 | -7,635 | -7,387 |
| Operating Cash Flow | $-8,228 | $-4,975 | $-8,685 | $-7,825 | $-7,365 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -143 | -14 | -2 | -32 | -12 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 7,789 |
| Other Investing Activity | 9,157 | 11,341 | 214 | 3,205 | 0 |
| Investing Cash Flow | $9,014 | $11,328 | $212 | $3,174 | $7,777 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -67 | -18 | -30 | -14 | -22 |
| Common Stock Issued | 8,378 | 0 | 0 | N/A | N/A |
| Other Financing Activity | 5,738 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $14,049 | $-18 | $-30 | $-14 | $-22 |
| Exchange Rate Effect | -202 | 723 | -482 | 252 | 424 |
| Beginning Cash Position | 15,602 | 9,366 | 17,964 | 22,775 | 21,961 |
| End Cash Position | 30,234 | 15,295 | 9,366 | 17,964 | 22,775 |
| Net Cash Flow | $14,834 | $6,335 | $-8,503 | $-4,666 | $389 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,228 | -4,975 | -8,685 | -7,825 | -7,365 |
| Capital Expenditure | -143 | -14 | -2 | -32 | -12 |
| Free Cash Flow | -8,371 | -4,989 | -8,687 | -7,857 | -7,377 |